Although that book does mention the PSA test (which is notoriously unreliable)
for detecting prostate cancer, it is noteworthy that the above list includes
two predominantly female organs (mammary glands and ovaries), but no male
Although men do have 460 deaths annually from breast cancer, they also
have 26,730 deaths annually from prostate cancer, 410 deaths annually
from testicular cancer and 360 deaths annually from cancer of the penis
and other genital cancers.
So, according to Thieman &Palladino, it appears that US scientists
are "particularly interested" in ovarian
cancer (14,080 deaths annually) but not particularly
interested in prostate cancer (26,730 deaths annually).
So US medical science seems to be more concerned with women's health
than with men's health.
Update 1: However,
Dr. David Ackerley pointed out to me in the online discussion forum
for the BTEC101 course which he taught at Victoria University of Wellington
in 2017 that US cancer research funding has actually been allocated
to ovarian cancer ($23,926,000) and prostate cancer ($40,227,752) in
a proportion which roughly reflects the above numbers of deaths. See:
Grants by Cancer Type.